These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 6800533)
1. Treatment of hypertension with ketanserin, a new selective 5-HT2 receptor antagonist. Wenting GJ; Man in 't Veld AJ; Woittiez AJ; Boomsma F; Schalekamp MA Br Med J (Clin Res Ed); 1982 Feb; 284(6315):537-9. PubMed ID: 6800533 [TBL] [Abstract][Full Text] [Related]
2. 5-HT, alpha-adrenoceptors, and blood pressure. Effects of ketanserin in essential hypertension and autonomic insufficiency. Wenting GJ; Woittiez AJ; Man in't Veld AJ; Schalekamp MA Hypertension; 1984; 6(1):100-9. PubMed ID: 6319278 [TBL] [Abstract][Full Text] [Related]
3. Ketanserin: a possible tool for studying the role of serotonin in hypertension. Woittiez AJ; Wenting GJ; Man in't Veld AJ; Boomsma F; Schalekamp MA J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S130-6. PubMed ID: 2412035 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular effects of ketanserin in the treatment of hypertension during coronary artery bypass surgery. Richter JA; Barankay A; Göb E; Späth P J Cardiovasc Pharmacol; 1986; 8(1):109-15. PubMed ID: 2419672 [TBL] [Abstract][Full Text] [Related]
5. 5-HT2-receptor blockade in the treatment of heart failure. A preliminary study. Demoulin JC; Bertholet M; Soumagne D; David JL; Kulbertus HE Lancet; 1981 May; 1(8231):1186-8. PubMed ID: 6112531 [TBL] [Abstract][Full Text] [Related]
7. Effects of serotonin on the cardiopulmonary circulatory system with and without 5-HT2-receptor blockade by ketanserin. Breuer J; Meschig R; Breuer HW; Arnold G J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S64-6. PubMed ID: 2412062 [TBL] [Abstract][Full Text] [Related]
8. Ketanserin, a serotonin antagonist. Administration in patients with acute respiratory failure. Vincent JL; Degaute JP; Domb M; Simon P; Berre J; Vandesteene A Chest; 1984 Apr; 85(4):510-3. PubMed ID: 6705581 [TBL] [Abstract][Full Text] [Related]
9. Long-term effects on central haemodynamics and body fluid volumes of ketanserin in essential hypertension studies at rest and during dynamic exercise. Omvik P; Lund-Johansen P J Hypertens; 1983 Dec; 1(4):405-12. PubMed ID: 6681181 [TBL] [Abstract][Full Text] [Related]
10. The use of ketanserin, a 5-hydroxytryptamine receptor antagonist, for treatment of postoperative hypertension following coronary artery bypass surgery. van der Starre PJ; Scheijgrond HW; Reneman RS; Kolling JB Anesth Analg; 1983 Jan; 62(1):63-9. PubMed ID: 6600382 [TBL] [Abstract][Full Text] [Related]
11. Does acute serotonergic type-2 antagonism reduce blood pressure? Comparative effects of single doses of ritanserin and ketanserin in essential hypertension. Hosie J; Stott DJ; Robertson JI; Ball SG J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S86-8. PubMed ID: 2446081 [TBL] [Abstract][Full Text] [Related]
12. Antihypertensive effects of ketanserin and ritanserin in the spontaneously hypertensive rat. Persson B; Gradin K; Pettersson A; Hedner T J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S22-4. PubMed ID: 2459509 [TBL] [Abstract][Full Text] [Related]
13. Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension. Zabludowski JR; Zoccali C; Isles CG; Murray GD; Robertson JI; Inglis GC; Fraser R; Ball SG Br J Clin Pharmacol; 1984 Mar; 17(3):309-16. PubMed ID: 6712863 [TBL] [Abstract][Full Text] [Related]
14. Blood pressure, 5-OH indoleacetic acid, and vanilmandelic acid excretion and blood platelet aggregation in hypertensive patients treated with ketanserin. Dzúrik R; Fetkovská N; Brimichová G; Tison P J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S29-31. PubMed ID: 2412052 [TBL] [Abstract][Full Text] [Related]
15. Effect of ketanserin on hemodynamics, plasma-catecholamine concentrations, and serotonin uptake by platelets in volunteers and patients with congestive heart failure. Grobecker H; Gessler I; Delius W; Dominiak P; Kees F J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S102-4. PubMed ID: 2412024 [TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of ketanserin, a new antiserotonergic agent in the treatment of arterial hypertension. Ferrara LA; Fasano ML; Soro S; Rubba P; Iannuzzi A J Clin Pharmacol; 1985 Apr; 25(3):187-92. PubMed ID: 3158674 [TBL] [Abstract][Full Text] [Related]
17. Chronic effect of ketanserin in mild to moderate essential hypertension. Woittiez AJ; Wenting GJ; van den Meiracker AH; Ritsema van Eck HJ; Man in't Veld AJ; Zantvoort FA; Schalekamp MA Hypertension; 1986 Feb; 8(2):167-73. PubMed ID: 2935497 [TBL] [Abstract][Full Text] [Related]